1. Stables CL, Glasser RL, Feldman EL. Diabetic cardiac autonomic neuropathy: insights from animal models. Auton Neurosci. 2013;177(2):74–80.
2. Suryavanshi SV, Kulkarni YA. NF-κβ: a potential target in the management of vascular complications of diabetes. Front Pharmacol. 2017;8:798–12.
3. Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res. 2001;44(3):183–93.
4. Rimmon A, Vexler A, Berkovich L, Earon G, Ron I, Lev-Ari S. Escin chemosensitizes human pancreatic cancer cells and inhibits the nuclear factor-kappaB signaling pathway. Biochem Res Int. 2013;2013:251752.
5. Lee HS, Hong JE, Kim EJ, Kim SH. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells. Nutr Cancer. 2014;66(6):938–45.